Austin, United States, May 22, 2026 (GLOBE NEWSWIRE) -- "SNS Insider reported that global Vascular Closure Devices Market was valued at USD 1.92 billion in 2025 and is projected to reach USD 4.08 ...

Dot Medical announced today that it received FDA investigational device exemption (IDE) approval for its access management ...

Haemonetics Corporation HAE recently gained CE mark certification for the VASCADE vascular closure and VASCADE MVP venous vascular closure systems. The VASCADE system is intended for ‘small-bore’ ...

Hyderabad, India, June 08, 2026 (GLOBE NEWSWIRE) -- According to the latest report by Mordor Intelligence, the vascular closure devices market size was valued at USD 1.77 billion in 2025 and is ...

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that it will unveil the results of its U.S ...

Approval brings proven technology of the MYNX family of products to mid-bore venous puncture sites, including electrophysiology procedures. MIAMI, July 9, 2024 /PRNewswire/ -- Cordis, a global leader ...

WASHINGTON, DC—For vascular closure after transfemoral TAVI, a strategy that combines suture- and plug-based devices halves the risk of access site-related vascular complications during a patient’s’ ...

The explosion of innovation in valve replacement and repair markets is opening a huge opportunity for percutaneous vessel closure devices. Edward Lifesciences’s FDA nod for the Evoque Transcatheter ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...